Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

IMVARIA Inc. is a software-as-medical-device (SaMD) company founded in 2019, specializing in AI-driven digital biomarker solutions for improving clinical decision-making. Their core products,…

IMVARIA Inc. is a software-as-medical-device (SaMD) company founded in 2019, specializing in AI-driven digital biomarker solutions for improving clinical decision-making. Their core products,…
Founded: 2019
Headquarters: Berkeley, California, United States
Focus: AI-driven digital biomarker and diagnostic solutions for lung disease (ILD/IPF)
Flagship products: Fibresolve (FDA-authorized), ScreenDx (FDA 510(k)-cleared)
Employee count: 7
Diagnostic imaging and digital biomarkers for pulmonary disease (interstitial lung disease, idiopathic pulmonary fibrosis)
2019
Biotechnology
Awarded a Phase I SBIR to support development of a CT-based malignancy assessment product
Company announced strategic investments from new and existing investors to accelerate growth
“Company lists investors including Cedar Crest Holdings, Creative Ventures, InHealth Ventures, John Capodilupo, Kevin Moore, LabCorp Venture Fund, Meridian Street Capital, National Institutes of Health, and TMU BioMed Accelerator”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week